Renli Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renli Huang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Zhaowei Zou
Department of General Surgery, Zhujiang Hospital, The Second School of Clinical Medicine Southern Medical University Guangzhou China
4 shared publications- Jinlong Yu
Department of General Surgery, Zhujiang Hospital Southern Medical University Guangzhou Guangdong China
3 shared publications Cheng Wu
Department of Gastroenteric Hernia Ganzhou People's Hospital Ganzhou Jiangxi China
2 shared publicationsJialing Wen
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong China
2 shared publications- Zhaowei Zou
Department of General Surgery Zhujiang Hospital Southern Medical University Guangzhou 510282 China
2 shared publications Bin Liu
Department of Emergency, Zhujiang Hospital, Southern Medical University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (3) , 1339-1346
A modified combined approach in laparoscopic right hemicolectomy for right-sided colon based on surgical trunk orientation: a case of a new surgical technique
Colorectal cancer remains a significant threat to human life and health, with Laparoscopic technology represents a pivotal advancement in its treatment. Laparoscopic right hemicolectomy has emerged as the preferred surgical modality for managing right-sided colon cancer, offering minimally invasive benefits and expedited recovery. However, the right colon anatomy, characterized by complex vascular branching patterns and frequent variations, presents significant surgical challenges. Various surgical access methods have been proposed to address these challenges, each with distinct advantages and limitations. To optimize surgical outcomes, our research team has meticulously analyzed these approaches and developed a modified combined approach for laparoscopic right hemicolectomy in the treatment of right-sided colon cancer. This innovative approach integrates the strengths of different methods to enhance surgical efficacy while minimizing intraoperative bleeding, facilitating rapid recovery, and ensuring favorable prognosis. We report a case of a 76-year-old male with hypertension who presented with rectal bleeding. Preoperative evaluation revealed moderately differentiated adenocarcinoma in the ascending colon (clinical stage T3N1bM0). The patient underwent the modified combined approach of laparoscopic right hemicolectomy. The surgery was successful, with few intraoperative complications. Postoperatively, the patient had an uneventful recovery, was discharged after 8 days, and showed no signs of recurrence at 6-month follow-up. We anticipate that this novel surgical approach will provide more precise and efficient treatment options, ultimately improving the overall quality of life for patients with right-sided colon cancer.
- 1 June 2025
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 16 (3) , 1339-1346
Open AccessA modified combined approach in laparoscopic right hemicolectomy for right-sided colon based on surgical trunk orientation: a case of a new surgical technique
Colorectal cancer remains a significant threat to human life and health, with Laparoscopic technology represents a pivotal advancement in its treatment. Laparoscopic right hemicolectomy has emerged as the preferred surgical modality for managing right-sided colon cancer, offering minimally invasive benefits and expedited recovery. However, the right colon anatomy, characterized by complex vascular branching patterns and frequent variations, presents significant surgical challenges. Various surgical access methods have been proposed to address these challenges, each with distinct advantages and limitations. To optimize surgical outcomes, our research team has meticulously analyzed these approaches and developed a modified combined approach for laparoscopic right hemicolectomy in the treatment of right-sided colon cancer. This innovative approach integrates the strengths of different methods to enhance surgical efficacy while minimizing intraoperative bleeding, facilitating rapid recovery, and ensuring favorable prognosis. We report a case of a 76-year-old male with hypertension who presented with rectal bleeding. Preoperative evaluation revealed moderately differentiated adenocarcinoma in the ascending colon (clinical stage T3N1bM0). The patient underwent the modified combined approach of laparoscopic right hemicolectomy. The surgery was successful, with few intraoperative complications. Postoperatively, the patient had an uneventful recovery, was discharged after 8 days, and showed no signs of recurrence at 6-month follow-up. We anticipate that this novel surgical approach will provide more precise and efficient treatment options, ultimately improving the overall quality of life for patients with right-sided colon cancer.
- 21 April 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (7) , 1461-1462
Laparoscopic complete right hemicolectomy: Surgical trunk‐oriented adjuvant radical surgery for right hemicolonic carcinoma—A video vignette
- 21 April 2024
- Published by Wiley in Colorectal Disease
- Vol. 26 (7) , 1461-1462
Laparoscopic complete right hemicolectomy: Surgical trunk‐oriented adjuvant radical surgery for right hemicolonic carcinoma—A video vignette
- Open Access
- 11 May 2022
- Published by Wiley in Cancer Medicine
- Vol. 11 (23) , 4688-4702
DIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation
Background: Actin cytoskeleton is connected with the processes of cell proliferation and migration in colorectal cancer (CRC). However, it is unknown how to accomplish these adjustments in CRC by actin cytoskeleton genes (ACGs) and here we investigated the role of hub prognosis‐related ACGs‐Diaphanous‐related formin 3 (DIAPH3) in CRC, as a potential, novel target.Methods: The ACGs gene set from the Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to group CRC patients and select prognosis‐related ACGs by univariate and multivariate Cox regression for constructing prognostic model. Next, we tested hub prognosis‐related ACGs‐ DIAPH3 expression in CRC and clarified the role of DIAPH3 by shRNA constructs in KM12 and SW480. Activation of EGFR was analyzed by western blot and immunofluorescence.Results: The results showed that actin cytoskeleton function is a significant prognostic factor for CRC patients and related to clinicopathological characteristics such as T stage and lymph node metastasis. A prognostic model constructed by four prognosis‐related ACGs has a moderate intensity to 1‐year Survival (AUC = 0.71). And hub prognosis‐related ACGs DIAPH3 is downregulated in CRC. Knockdown of DIAPH3 could promote the proliferation and migration capacity of CRC. In addition, DIAPH3‐silenced cells increase EGFR phosphorylation by inhibiting EGFR transportation to lysosome.Conclusions: ACGs play a significant role in tumor invasion and have the potential to predict the prognosis of CRC. Prognosis‐related ACGs DIAPH3 might be a new prognostic biomarker and DIAPH3 could inhibit CRC progression through maintaining EGFR degradation.
- 11 May 2022
- Published by Wiley in Cancer Medicine
- Vol. 11 (23) , 4688-4702
Open AccessDIAPH3 is a prognostic biomarker and inhibit colorectal cancer progression through maintaining EGFR degradation
Background: Actin cytoskeleton is connected with the processes of cell proliferation and migration in colorectal cancer (CRC). However, it is unknown how to accomplish these adjustments in CRC by actin cytoskeleton genes (ACGs) and here we investigated the role of hub prognosis‐related ACGs‐Diaphanous‐related formin 3 (DIAPH3) in CRC, as a potential, novel target.Methods: The ACGs gene set from the Kyoto Encyclopedia of Genes and Genomes (KEGG) was used to group CRC patients and select prognosis‐related ACGs by univariate and multivariate Cox regression for constructing prognostic model. Next, we tested hub prognosis‐related ACGs‐ DIAPH3 expression in CRC and clarified the role of DIAPH3 by shRNA constructs in KM12 and SW480. Activation of EGFR was analyzed by western blot and immunofluorescence.Results: The results showed that actin cytoskeleton function is a significant prognostic factor for CRC patients and related to clinicopathological characteristics such as T stage and lymph node metastasis. A prognostic model constructed by four prognosis‐related ACGs has a moderate intensity to 1‐year Survival (AUC = 0.71). And hub prognosis‐related ACGs DIAPH3 is downregulated in CRC. Knockdown of DIAPH3 could promote the proliferation and migration capacity of CRC. In addition, DIAPH3‐silenced cells increase EGFR phosphorylation by inhibiting EGFR transportation to lysosome.Conclusions: ACGs play a significant role in tumor invasion and have the potential to predict the prognosis of CRC. Prognosis‐related ACGs DIAPH3 might be a new prognostic biomarker and DIAPH3 could inhibit CRC progression through maintaining EGFR degradation.
- Open Access
- 28 October 2019
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-15
BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways
Background: BMP3 gene is often found hypermethylated and hence inactivated in several types of cancers including colorectal cancer (CRC), indicating that it has a suppressor role in carcinogenesis. Though BMP3 is a reliable biomarker for screening CRC, the molecular mechanism of BMP3 in carcinogenesis remains largely unknown.Methods: The expression level of BMP3 was examined by immunohistochemistry staining and western blot. Methylation-specific PCR (MSP) and real-time quantitative MSP were used to test the hypermethylation status of BMP3 gene. Analyses of BMP3 function in colon cancer cell proliferation, migration, invasion, and apoptosis were performed using HCT116 and KM12 cells. BMP3 was further knocked down or overexpressed in CRC cells, and the effects on cell growth of xenograft tumors in nude mice were assessed. Co-immunoprecipitation and immunofluorescence staining were used to analyze the association between BMP3 and BMPR2 or BMP3 and ActRIIB. Microarray analysis was performed to identify most differentially expressed genes and pathways regulated by BMP3. The BMP3-regulated SMAD2-dependent signaling pathway and TAK1/JNK signal axes were further investigated by quantitative PCR and western blot.Results: BMP3 gene was hypermethylated and its expression was downregulated in both CRC tissues and cell lines. Expressing exogenous BMP3 in HCT116 inhibited cell growth, migration, and invasion and increased rate of apoptosis both in vitro and in vivo. However, shRNA-mediated attenuation of endogenous BMP3 in KM12 reversed such inhibitory and apoptotic effects. Furthermore, BMP3 could bind to ActRIIB, an activin type II receptor at the cellular membrane, thereby activating SMAD2-dependent pathway and TAK1/JNK signal axes to regulate downstream targets including caspase-7, p21, and SMAD4 that play crucial roles in cell cycle control and apoptosis.Conclusions: Our study reveals a previously unknown mechanism of BMP3 tumor suppression in CRC and provides a rationale for future investigation of BMP3 as a potential target for the development of novel therapeutic agents to fight CRC.
- 28 October 2019
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 38 (1) , 1-15
Open AccessBMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways
Background: BMP3 gene is often found hypermethylated and hence inactivated in several types of cancers including colorectal cancer (CRC), indicating that it has a suppressor role in carcinogenesis. Though BMP3 is a reliable biomarker for screening CRC, the molecular mechanism of BMP3 in carcinogenesis remains largely unknown.Methods: The expression level of BMP3 was examined by immunohistochemistry staining and western blot. Methylation-specific PCR (MSP) and real-time quantitative MSP were used to test the hypermethylation status of BMP3 gene. Analyses of BMP3 function in colon cancer cell proliferation, migration, invasion, and apoptosis were performed using HCT116 and KM12 cells. BMP3 was further knocked down or overexpressed in CRC cells, and the effects on cell growth of xenograft tumors in nude mice were assessed. Co-immunoprecipitation and immunofluorescence staining were used to analyze the association between BMP3 and BMPR2 or BMP3 and ActRIIB. Microarray analysis was performed to identify most differentially expressed genes and pathways regulated by BMP3. The BMP3-regulated SMAD2-dependent signaling pathway and TAK1/JNK signal axes were further investigated by quantitative PCR and western blot.Results: BMP3 gene was hypermethylated and its expression was downregulated in both CRC tissues and cell lines. Expressing exogenous BMP3 in HCT116 inhibited cell growth, migration, and invasion and increased rate of apoptosis both in vitro and in vivo. However, shRNA-mediated attenuation of endogenous BMP3 in KM12 reversed such inhibitory and apoptotic effects. Furthermore, BMP3 could bind to ActRIIB, an activin type II receptor at the cellular membrane, thereby activating SMAD2-dependent pathway and TAK1/JNK signal axes to regulate downstream targets including caspase-7, p21, and SMAD4 that play crucial roles in cell cycle control and apoptosis.Conclusions: Our study reveals a previously unknown mechanism of BMP3 tumor suppression in CRC and provides a rationale for future investigation of BMP3 as a potential target for the development of novel therapeutic agents to fight CRC.
- 25 September 2019
- Published by Wiley in Colorectal Disease
- Vol. 22 (2) , 224-225
Amelioration of intersphincteric resection for low rectal cancer – concentrate on defaecation function – a video vignette
- 25 September 2019
- Published by Wiley in Colorectal Disease
- Vol. 22 (2) , 224-225
Amelioration of intersphincteric resection for low rectal cancer – concentrate on defaecation function – a video vignette
- Open Access
- 5 March 2019
- Published by Wiley in Mediators of Inflammation
- Vol. 2019, 1-13
Cx43 Inhibition Attenuates Sepsis-Induced Intestinal Injury via Downregulating ROS Transfer and the Activation of the JNK1/Sirt1/FoxO3a Signaling Pathway
Intestinal injury has long been considered to play a crucial role in the pathophysiology of sepsis and has even been characterized as the “motor” of it. Thus, we explored the effects of connexin43 (Cx43) on sepsis-induced intestinal injury in order to provide potential therapeutic strategies. Rat cecal ligation and puncture (CLP) models in vivo and cell models (IEC-6 cells) pretreated with LPS in vitro were used in the current study. Firstly, different methods, such as Cx43 inhibitors (18-α-GA and oleamide) or siRNA targeting Cx43 and N-acetyl cysteine (NAC) (a kind of ROS scavenger), were used to observe the effects of Cx43 channels mediating ROS transfer on intestinal injury. Secondly, the influence of ROS content on the activity of the JNK1/Sirt1/FoxO3a signaling pathway was explored through the application of NAC, sp600125 (a JNK1 inhibitor), and nicotinamide (a Sirt1 inhibitor). Finally, luciferase assays and ChIP were used to determine the direct regulation of FoxO3a on proapoptotic proteins, Bim and Puma. The results showed that sepsis-induced intestinal injury presented a dynamic change, coincident with the alternation of Cx43 expression. The inhibition of Cx43 attenuated CLP-induced intestinal injury in vivo and LPS-induced IEC-6 injury in vitro. The changes of Cx43 channel function regulated ROS transfer between the neighboring cells, which mediated the activation of the JNK1/Sirt1/FoxO3a signaling pathway. FoxO3a directly affected its downstream target genes, Bim and Puma, which are responsible for cell or tissue apoptosis. In summary, our results suggest that Cx43 inhibition suppresses ROS transfer and inactivates the JNK1/Sirt1/FoxO3a signaling pathway to protect against sepsis-induced intestinal injury.
- 5 March 2019
- Published by Wiley in Mediators of Inflammation
- Vol. 2019, 1-13
Open AccessCx43 Inhibition Attenuates Sepsis-Induced Intestinal Injury via Downregulating ROS Transfer and the Activation of the JNK1/Sirt1/FoxO3a Signaling Pathway
Intestinal injury has long been considered to play a crucial role in the pathophysiology of sepsis and has even been characterized as the “motor” of it. Thus, we explored the effects of connexin43 (Cx43) on sepsis-induced intestinal injury in order to provide potential therapeutic strategies. Rat cecal ligation and puncture (CLP) models in vivo and cell models (IEC-6 cells) pretreated with LPS in vitro were used in the current study. Firstly, different methods, such as Cx43 inhibitors (18-α-GA and oleamide) or siRNA targeting Cx43 and N-acetyl cysteine (NAC) (a kind of ROS scavenger), were used to observe the effects of Cx43 channels mediating ROS transfer on intestinal injury. Secondly, the influence of ROS content on the activity of the JNK1/Sirt1/FoxO3a signaling pathway was explored through the application of NAC, sp600125 (a JNK1 inhibitor), and nicotinamide (a Sirt1 inhibitor). Finally, luciferase assays and ChIP were used to determine the direct regulation of FoxO3a on proapoptotic proteins, Bim and Puma. The results showed that sepsis-induced intestinal injury presented a dynamic change, coincident with the alternation of Cx43 expression. The inhibition of Cx43 attenuated CLP-induced intestinal injury in vivo and LPS-induced IEC-6 injury in vitro. The changes of Cx43 channel function regulated ROS transfer between the neighboring cells, which mediated the activation of the JNK1/Sirt1/FoxO3a signaling pathway. FoxO3a directly affected its downstream target genes, Bim and Puma, which are responsible for cell or tissue apoptosis. In summary, our results suggest that Cx43 inhibition suppresses ROS transfer and inactivates the JNK1/Sirt1/FoxO3a signaling pathway to protect against sepsis-induced intestinal injury.